Drug Interactions III. Classes of Drugs Autonomic Drugs: Sympathomimetic (Adrenergic) Agents

Anon.: Interaction of Drugs, Brit. Med. J. 1: 811 (Apr. 2) 1966. (R).

Anon.: Interaction of Monoamine Oxidase Inhibitors and Drugs Used in Dentistry, Med. J. Australia 1: 1092 (June 18) 1966. (R).

Anon.: Anaesthetics and the Heart, Lancet 1: 484 (Mar. 4) 1967. (R).

Anon.: Insulin and Epinephrine, S. African Med. J. 41: 474 (May 14) 1967. (R).

Anon.: Drug Interactions That Can Affect Your Patients, Patient Care 1: 32 (Nov.) 1967. (R).

American Hospital Formulary Service, American Society of Hospital Pharmacists, Washington D.C. (R). a. levarterenol. b. azapetine. c. phentolamine. d. MAOI. e. tranylcypromine. f. phenothiazine. g. cyclopropane. h. isoniazid. i. glucose oxidase reagent.

Sister M : Antonita: Necessary Precautions When Dispensing Oral Progestational Drugs to Inpatients, Hosp. Form. Manage. 3: 34 (Feb.) 1968. (R).

Asatoor A. M. Levi A. J. Milne M. D. : Tranylcypromine and Cheese, Lancet 2: 733 (Oct. 5) 1963. (CHO).

Belam O. H. : Anaesthesia and Therapeutic Drug, Postgrad. Med. J. 42: 374–77 (June) 1966. (R).

Bester J. F. : Potentiation of Drugs by Ethyl Alcohol, Am. Assoc. Indust. Nurse J. 15: 10 (Aug.) 1967. (R).

Blackwell B. : Tranylcypromine, Lancet 2: 414 (Aug. 24) 1963. (CH).

Block L. H. Lamy P. P. : Drug Interactions … with Emphasis on O-T-C-Drugs, J. Am. Pharm. Assoc. NS9: 202 (May) 1969. (R).

Block L. H. Lamy P. P. : Therapeutic Incompatibilities. Legend Drugs with O-T-C-Drugs, J. Am. Pharm. Assoc. NS8: 66 (Feb.) 1968. (R).

Bull C. : Hypertension with Methionine in Schizophrenic Patients Receiving Tranylcypromine, Am. J. Psychiat. 121: 381 (Oct.) 1964. (OH).

Burns J. J. : Application of Metabolic Data to the Evaluation of Drugs, Clin. Pharmacol Therap. 10: 607 (Sept.-Oct.) 1969. (R).

Casady G. N. Moore D. C. Bridenbaugh L. D. : Postpartum Hypertension after Use of Vasoconstrictor and Oxytocic Drugs. Etiology, Incidence, Complications, J. Am. Med. Assoc. 172: 1011 (Mar. 5) 1960. (RH).

Chang C. C. Costa E. Brodie B. B. : Reserpine Induced Release of Drugs from Sympathetic Nerve Endings, Life Sci. 3: 839, 1964.

Chu J. Doering M. F. Fogel E. J. : Clinical Determination of Unique Effect of Potentiation of Phenothiazine Medication by Nylidrin Hydrochloride, Intern. J. Neuro psychiat. 2: 53 (Jan.-Feb.) 1966. (OH).

Contreras E. Tamayo L. : Effects of Drugs Acting in Relation to Sympathetic Junctions on the Analgesic Action of Morphine, Arch. Intern. Pharmacodyn. 160: 312 (Apr.) 1966. (OA).

Cooper B. : “Neo-Synephrine” (10%) Eye Drops, Med. J. Australia 2: 420 (Aug. 31) 1968. (CH).

Cuthbert M. F. Greenberg M. D. Morley S. W. : Cough and Cold Remedies: A Potential Danger to Patients on Monoamine Oxidase Inhibitors, Brit. Med. J. 1: 404 (Feb.) 1969. (CH).

Day M. D. Rand M. J. : Antagonism of Guanethidine by Dexamphetamine and Other Related Sympathomimetic Amines, J. Pharm. Pharmacol. 14: 541 (Sept.) 1962. (OA).

Dixon R. L. Rogers L. A. Fouts J. A. : Effects of Norepinephrine Treatment on Drug Metabolism by Liver Microsomes from Rats, Biochem. Pharmacol. 13: 623 (Apr.) 1964. (OA).

Dollery C. T. : Physiological and Pharmacological Interactions of Antihypertensive Drugs. (In Symposium No. 7: Clinical Effects of Interaction Between Drugs). Proc. Roy. Soc. Med. 58: 983–87 (Nov.) 1965. (R).

Duvernoy W. F. C. : Positive Phentolamine Test in Hypertension Induced by a Nasal Decongestant, New Engl. J. Med. 280: 877 (Apr. 17) 1969. (CH).

Eble J. N. Rudzik A. D. : Tyramine and Amphetamine, Lancet 1: 766 (Apr. 2) 1966. (OA).

Eble J. N. Rudzik A. D. : Amphetamine: Augmentation of Pressor Effects of Tyramine in Rats, Proc. Soc. Exptl. Biol. Med. 122: 1059–60 (Aug.-Sept.) 1966. (OA).

Elis J. : Modification by Monoamine Oxidase Inhibitors of the Effect of Some Sympathomimetics on Blood Pressure, Brit. Med. J. 2: 75 (Apr.) 1967. (OH).

Elking M. P. Sister Kabat H. F. : Drug Induced Modifications of Laboratory Test Values, Am. J. Hosp. Pharm. 25: 485 (Sept.) 1958. (R).

Forman D. T. : Effect of Variables on Chemical and Diagnostic Specificity of Laboratory Tests, Memo to Attending Staff, Evanston Hospital. (R).

Gaddum J. H. Kwiatkowski H. : Action of Ephedrine, J. Physiol. 94: 87 (Oct. 14) 1938. (OA).

Gelder M. G. Vane J. R. : Interaction of the Effects of Tyramine, Amphetamine and Reserpine in Man, Psychopharmacologia 3: 231, 1962. (OH).

Goodman L. S. Gilman A. : The Pharmacological Basis of Therapeutics, 3rd. edition, The MacMillan Co., New York, 1965. (R).

Goth A. : Medical Pharmacology, 4th edition, The C. V. Mosby Co., St. Louis, 1968. (R).

Grant E. C. G. Mears E. : Mental Effects of Oral Contraceptives, Lancet 2: 945 (Oct.) 1967. (OH).

Greenberg M. J. : Isoprenaline in Myocardial Failure, Lancet 2: 442 (Aug. 28) 1965. (CH).

Hirsch M. S. Walter R. M. Hasterlik R. J. : Subarachnoid Hemorrhage Following Ephedrine and MAO Inhibitors, J. Am. Med. Assoc. 194: 1259 (Dec. 13) 1965. (CH).

Horler A. R. Wynne N. A. : Hypertensive Crisis Due to Pargyline and Metaraminol, Brit. Med. J. 2: 460 (Aug. 21) 1965. (CH).

Hrdina P. Garattini S. : Desipramine and Potentiation of Noradrenaline in the Isolated Perfused Renal Artery, J. Pharm. Pharmacol. 18: 259 (Apr.) 1966. (OT).

Hussar D. A. : Therapeutic Incompatibilities: Drug Interactions, Am. J. Pharm. 139: 215 (Nov.-Dec.) 1967. (R).

Hussar D. A. : Mechanisms of Drug Interactions, J. Am. Pharm. Assoc. NS9: 208 (May) 1969. (R).

Innes I. R. : Sensitization of the Heart and Nictitating Membrane of the Cat to Sympathomimetic Amines by Antihistamine Drugs, Brit. J. Pharmacol. 13: 6 (Mar.) 1958. (OA).

Isaac L. Goth A. : Mechanism of the Potentiation of Norepinephrine by Antihistaminics, J. Pharmacol. Exptl. Therap. 156: 463–8 (June) 1967. (OA).

Isaac L. Goth A. : Interaction of Antihistaminics with Norepinephrine Uptake: A Cocaine-Like Effect, Life Sci. 4: 1899 (Oct.) 1965. (OA).

Jori A. Garattini S. : Interaction Between Imipramine-Like Agents and Catecholamine-Induced Hyperthemia, J. Pharm. Pharmacol. 17: 480–8 (Aug.) 1965. (OA).

Jori A. Carrara M. C. Garattnis S. : Importance of Noradrenaline Synthesis for the Interaction Between Desipramine and Reserpine, J. Pharm. Pharmacol. 18: 619 (Sept.) 1966. (OA).

Katz R. L. Epstein R. A. : Interaction of Anesthetic Agents and Adrenergic Drugs to Produce Cardiac Arrhythmias, Anesthesiology 29: 763 (July-Aug.) 1968. (R).

Kimbelberg H. Moran J. F. Triggle J. D. : Mechanism of Interaction of 2-Halogenoethylamines at the Noradrenaline Receptor, J. Theoret. Biol. 9: 502–3 (Nov.) 1965.

Mason A. M. S. Buckle R. M. : “Cold” Cures and Monoamine-Oxidase Inhibitors. (CH).

McIver A. K. : Drug Interactions, Pharm. J. 199: 205, 1967. (R).

McIver A. K. : Drug Interactions, Pharm. J. 759: 548 (Nov. 25) 1967. (R).

Mond E. Mack I. : Cardiac Toxicity of Iproniazid (Marsilid): Report of Myocardial Injury in a Patient Receiving Levarterenol, J. Am. Heart Assoc. 59: 134, 1960. (CH).

Morrelli H. F. Melmon K. L. : Clinician's Approach to Drug Interactions, Calif. Med. 109: 380 (Nov.) 1968. (R).

Murray K. M. F. Smith S. E. : Desipramine and Hypertensive Episodes, Lancet 2: 591 (Sept. 10) 1966. (R).

Poyart C. : Depression of Norepinephrine Activity by Acidosis: Its Reversal by Aminophylline, Surg. Forum 17: 41–2, 1966. (OA).

Roberts J. : Influence of Reserpine and Beta TM 10 on Digitalis-Induced Ventricular Arrhythmia, Circ. Res. 13: 149 (Aug.) 1963. (OAT).

Roche Laboratories, Drug Brochure “Matulane” Aug. 1969. (R).

Sherrod T. R. Loew E. R. Schloemer H. F. : Pharmacological Properties of Antihistamine Drugs, Benadryl, Pyribenzamine and NeoAntergan, J. Pharmacol. Exptl. Therap. 89: 247 (Mar.) 1947. (OA).

Sjoqvist F. : Psychotropic Drugs (2) Interaction Between Monoamine Oxidase (MA) Inhibitors and Other Substances, Proc. Roy. Soc. Med. 58: 967 (Nov.) 1967. (R).

Smith M. C. Visconti J. A. : Adverse Drug Reactions … How Community Rx men can Help Prevent Them, Am. Prof. Pharmacist 34: 26 (Oct.) 1968. (R).

Stuart D. M. : Drug Metabolism Part II. Drug Interaction, pharm-Index 10: 4 (Oct.) 1968. (R).

Tonks C. M. Lloyd A. T. : Hazards with Monoamine-Oxidase Inhibitors, Brit. Med. J. 1: 589 (Feb. 27) 1965. (CH).

Winters W. L. Jr. Soloff L. A. : Observations on Sodium D-Thyroxine as a Hypocholesteremic Agent in Persons with Hypercholestermia with and without Ischemic Heart Disease, Am. J. Med. Sci. 243: 458 (Apr.) 1962. (OH) (OH).

Wirth W. A. Thompson R. L. : Effect of Various Conditions and Substances on the Results of Laboratory Procedures, Am. J. Clin. Pathol. 43: 579 (June) 1965. (R) Additional References NOT Reviewed By The Author.

Besse J. C. Bass A. D. : Potentiation by Hydrocortisone of Responses to Catecholamines in Vascular Smooth Muscle, J. Pharmacol. Exptl. Therap. 154: 224–38 (Nov.). 1966.

Bonaccorsi A. Garattine S. : Effect of Desipramine on Directly or Indirectly Elicited Catecholamine Pressor Responses in Rats, J. Pharm. Pharmacol. 18: 443–8 (July) 1966.

Brittain R. T. : Intracerebral Effects of Noradrenaline and Its Modification by Drugs in the Mouse, J. Pharm. Pharmacol. 18: 621–3 (Sept.) 1966.

Ellis S. : Physiological Interactions of Epinephrine and Insulin on Metabolism, Israel J. Med. Sci. 2: 673–6 (Nov.) 1966.

Goldberg A. M. Shideman F. E. : Negative Inotropic Action of Ephedrine and Its Modification by Various Agents, J. Pharmacol. Exptl. Therap. 157: 49–54 (July) 1967.

Jori A. : Potentiation of Noradrenaline Toxicity by Drugs with Antihistamine Activity, J. Pharm. Pharmacol. 18: 824 (Dec.) 1966.

Laurence D. R. Nagle R. E. : Effect of Bretylium and Guanethidine on the Pressor Response to Noradrenaline and Angiotensin, Brit. J. Pharmacol. 21: 403 (Dec.) 1963.

Lefer A. M. Manwaring J. L. Verrier R. L. : Effect of Corticosteroids on the Cardiovascular Responses to Angiotensin and Norepinephrine, J. Pharmacol. Exptl. Therap. 154: 83–91 (Oct.) 1966.

Lowe R. F. : Acute Angle-Closure Glaucoma Precipitated by Miotic Plus Adrenaline Eye Drops, Med. J. Australia 2: 1037 (Nov. 26) 1966.

MacCannell K. L. Dresel P. E. : Potentiation by Thiopental of Cyclopropane-Adrenaline Cardiac Arrhythmias, Can. J. Physiol. Pharmacol. 42: 627–39 (Sept.) 1964.

Mann A. M. Hutchison J. L. : Manic Reaction Associated with Procarbazine Hydrochloride Therapy of Hodgkin's Disease, Can. Med. Assoc. J. 97: 1350 (Nov. 25) 1967.

McManis A. G. : Deaths Following I.V. Epinephrine in Patients Using Isoproterenol, Med. J. Australia 2: 76, 1964.

Peters G. Hodgson J. Donovan R. : Effects of Premedication with Chlorpheniramine in Reactions to Methyl Glucamine, Allergy 38: 74 (Aug.) 1966.

Poyart C. Nahas G. G. : Metabolic Effects of Theophylline and Norepinephrine in the Dog at Normal and Acid p H, Am. J. Physiol. 212: 1247–54 (June) 1967.

Rauzzino F. J. Seifter J. : Potentiation and Antagonism of Biogenic Amines, J. Pharmacol. Exptl. Therap. 157: 143–8 (July) 1967.

Refshauge W. D. : Deaths Due to Epinephrine and Self-Administered Isoproterenol, Med. J. Australia 1: 93, 1965.

Sharma P. L. : Interaction of Adrenergic Alpha and Beta-Receptor Blocking Agents on the Blood Pressure Response to Adrenaline and Noradrenaline, Quart, J. Exptl. Physiol. 51: 256–61 (Oct.) 1966.

Simonsson B. G. : Bronchodilating Effect of Brontine and Isoprenaline. Additive Action of Isoprenaline Inhalation Respective Epinephrine Injection, Med. Thorac. 21: 295–302, 1964.

Spano P. F. : Potentiation of the Noradrenaline-Releasing Action of Tyramine by Monoamine Oxidase Inhibitors, J. Pharm. Pharmacol. 18: 548 (Aug.) 1966.

Strong F. M. : Deleterious Compounds in Foods, Am. J. Clin. Nutr. 11: 500 (Nov.) 1962.

Svedmyr N. : Action of Tri-iodothryonine on Some Effects of Adrenaline and Noradrenaline in Man, Acta. Pharmacol. (Kobenhavn) 24: 203–16, 1966.

Svedmyr N. : Potentiation Risks in the Administration of Catecholamines to Patients Treated With Tricyclic Antidepressive Agents, Svenska Lakartidn. 65: 72 (Supp. 1) 1968.

Thomas J. : Sympathomimetic Amines Used for Asthma, Australasian J. Pharm. 47: 357, 1966.

White R. P. Cobb D. P. Breese G. R. : Acute Ergotropic Response Induced by Reserpine and Mephentermine, Intern. J. Neuropharmacol. 5: 143–54 (Mar.) 1966.